Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Éilis Dockry, Seónadh O'Leary, Laura E. Gleeson, Judith Lyons, Joseph Keane, Steven G. Gray & Derek G. Doherty. (2018) Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cells. OncoImmunology 7:6.
Read now
Read now
Archana Venkataramana Karanth, Radhika Radha Maniswami, Seema Prashanth, Hemalatha Govindaraj, Ramya Padmavathy, Sooriya Kumar Jegatheesan, Ramesh Mullangi & Sriram Rajagopal. (2017) Emerging role of SETDB1 as a therapeutic target. Expert Opinion on Therapeutic Targets 21:3, pages 319-331.
Read now
Read now
Hazem E. Hassan, Jean-Arnaud Keita, Lawrence Narayan, Sean M. Brady, Richard Frederick, Samuel Carlson, Karen C. Glass, Senthil Natesan, Thomm Buttolph & Tamer E. Fandy. (2016) The combination of dimethoxycurcumin with DNA methylation inhibitor enhances gene re-expression of promoter-methylated genes and antagonizes their cytotoxic effect. Epigenetics 11:10, pages 740-749.
Read now
Read now
Articles from other publishers (51)
Daniel Sanghoon Shin, Kevin Park, Edward Garon & Steven Dubinett. (2022) Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer. Seminars in Oncology 49:3-4, pages 306-318.
Crossref
Crossref
Zhong-Gui Gong, Yuan Zhao, Zhen-Yong Wang, Rui-Feng Fan, Zong-Ping Liu & Lin Wang. (2022) Epigenetic regulator BRD4 is involved in cadmium-induced acute kidney injury via contributing to lysosomal dysfunction, autophagy blockade and oxidative stress. Journal of Hazardous Materials 423, pages 127110.
Crossref
Crossref
Elham Zeinalzadeh, Alexey Valerievich Yumashev, Heshu Sulaiman Rahman, Faroogh Marofi, Navid Shomali, Hossein Samadi Kafil, Saeed Solali, Mehdi Sajjadi-Dokht, Sajjad Vakili-Samiani, Mostafa Jarahian & Majid Farshdousti Hagh. (2021) The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics. Frontiers in Genetics 12.
Crossref
Crossref
Zhonggui Gong, Gang Liu, Wenjing Liu, Hui Zou, Ruilong Song, Hongyan Zhao, Yan Yuan, Jianhong Gu, Jianchun Bian, Jiaqiao Zhu & Zongping Liu. (2021) The epigenetic regulator BRD4 is involved in cadmium-triggered inflammatory response in rat kidney. Ecotoxicology and Environmental Safety 224, pages 112620.
Crossref
Crossref
Li Yuan, Boshu Sun, Liangliang Xu, Limin Chen & Wenbin Ou. (2021) The Updating of Biological Functions of Methyltransferase SETDB1 and Its Relevance in Lung Cancer and Mesothelioma. International Journal of Molecular Sciences 22:14, pages 7416.
Crossref
Crossref
Yuqing Wang, Jie Huang, Qiong Wu, Jingjing Zhang, Zhiyuan Ma, Lucheng Zhu, Bin Xia, Shenglin Ma & Shirong Zhang. (2021) Decitabine Sensitizes the Radioresistant Lung Adenocarcinoma to Pemetrexed Through Upregulation of Folate Receptor Alpha. Frontiers in Oncology 11.
Crossref
Crossref
Yinping Guo, Xin Mao, Liang Xiong, Anjie Xia, Jing You, Guifeng Lin, Chengyong Wu, Luyi Huang, Yiwei Wang & Shengyong Yang. (2021) Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor Domain. Angewandte Chemie International Edition 60:16, pages 8760-8765.
Crossref
Crossref
Yinping Guo, Xin Mao, Liang Xiong, Anjie Xia, Jing You, Guifeng Lin, Chengyong Wu, Luyi Huang, Yiwei Wang & Shengyong Yang. (2021) Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor Domain. Angewandte Chemie 133:16, pages 8842-8847.
Crossref
Crossref
Che Othman Siti Sarah, Norasnieda Md Shukri, Noor Suryani Mohd Ashari & Kah Keng Wong. (2020) Zonula occludens and nasal epithelial barrier integrity in allergic rhinitis. PeerJ 8, pages e9834.
Crossref
Crossref
Jiayu Zhang, Cheng Yang, Chunfu Wu, Wei Cui & Lihui Wang. (2020) DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy. Cancers 12:8, pages 2123.
Crossref
Crossref
Trung Vu, Shanzhong Yang & Pran K. Datta. (2020) MiR-216b/Smad3/BCL-2 Axis Is Involved in Smoking-Mediated Drug Resistance in Non-Small Cell Lung Cancer. Cancers 12:7, pages 1879.
Crossref
Crossref
Wen-juan Liu, Yue Du, Ru Wen, Ming Yang & Jian Xu. (2020) Drug resistance to targeted therapeutic strategies in non-small cell lung cancer. Pharmacology & Therapeutics 206, pages 107438.
Crossref
Crossref
Leon P. Bignold. 2020. Principles of Tumors. Principles of Tumors
453
460
.
Pin‑Hao KoGovinda LenkaYu‑An ChenEric ChuangMong‑Hsun TsaiYuh‑Pyng SherLiang‑Chuan Lai. (2019) Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells. International Journal of Oncology.
Crossref
Crossref
Benjamin H. LokCharles M. Rudin. (2019) Epigenetic targeting of DNA repair in lung cancer. Proceedings of the National Academy of Sciences 116:45, pages 22429-22431.
Crossref
Crossref
Bin Shi, Carmen Behrens, Viralkumar Vaghani, Erick Marcelo Riquelme, Jaime Rodriguez‐Canales, Humam Kadara, Heather Lin, Jack Lee, Hui Liu, Ignacio Wistuba & George Simon. (2019) Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer. Cancer Medicine 8:14, pages 6383-6392.
Crossref
Crossref
Seok Kyo Seo, Jae Hoon Lee, Seung Joo Chon, Bo Hyon Yun, Sihyun Cho, Young Sik Choi & Byung Seok Lee. (2018) Trichostatin A Induces NAG-1 Expression and Apoptosis in Human Endometriotic Stromal Cells. Reproductive Sciences 25:9, pages 1349-1356.
Crossref
Crossref
Paul L. Feingold, Deborah R. Surman, Kate Brown, Yuan Xu, Lucas A. McDuffie, Vivek Shukla, Emily S. Reardon, Daniel R. Crooks, Jane B. Trepel, Sunmin Lee, Min-Jung Lee, Shaojian Gao, Sichuan Xi, Kaitlin C. McLoughlin, Laurence P. Diggs, David G. Beer, Derek J. Nancarrow, Leonard M. Neckers, Jeremy L. Davis, Chuong D. Hoang, Jonathan M. Hernandez, David S. Schrump & R. Taylor Ripley. (2018) Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma. Molecular Cancer Therapeutics 17:9, pages 2013-2023.
Crossref
Crossref
Yao Dong, Sheng Huaying, Wan Danying, Zhu Chihong, Jiang Ruibin, Sun Xiaojiang & Feng Jianguo. (2018) Significance of Methylation of FBP1 Gene in Non-Small Cell Lung Cancer. BioMed Research International 2018, pages 1-9.
Crossref
Crossref
Ite A. Laird-Offringa & Montse Sanchez-Cespedes. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology
104
116.e5
.
Mahdi Mahmoudi & Saeed Aslani. 2018. The Epigenetics of Autoimmunity. The Epigenetics of Autoimmunity
387
402
.
Ju Hwan Cho, Filiz Oezkan, Michael Koenig, Gregory A. Otterson, James Gordon Herman & Kai He. (2017) Epigenetic Therapeutics and Their Impact in Immunotherapy of Lung Cancer. Current Pharmacology Reports 3:6, pages 360-373.
Crossref
Crossref
Josep Mari-Alexandre, Angel Diaz-Lagares, Maria Villalba, Oscar Juan, Ana B. Crujeiras, Alfonso Calvo & Juan Sandoval. (2017) Translating cancer epigenomics into the clinic: focus on lung cancer. Translational Research 189, pages 76-92.
Crossref
Crossref
Jian Bai, Xue Zhang, Bangqing Liu, Haiyong Wang, Zhenzong Du & Jianfei Song. (2017) Silencing DNA methyltransferase 1 leads to the activation of the esophageal suppressor gene p16 in vitro and in vivo. Oncology Letters 14:3, pages 3077-3081.
Crossref
Crossref
Kara Wegermann & Cynthia A. Moylan. (2017) Epigenetics of Childhood Obesity. Current Pediatrics Reports 5:3, pages 111-117.
Crossref
Crossref
Jiunn-Min Shieh, Yen-An Tang, Fu-Han Hu, Wei-Jan Huang, Ying-Jan Wang, Jayu Jen, Sheng-You Liao, Ying-Hung Lu, Ya-Ling Yeh, Tseng-Wei Wang, Pinpin Lin & Yi-Ching Wang. (2017) A histone deacetylase inhibitor enhances expression of genes inhibiting Wnt pathway and augments activity of DNA demethylation reagent against nonsmall-cell lung cancer. International Journal of Cancer 140:10, pages 2375-2386.
Crossref
Crossref
O A Romero, S Verdura, M Torres-Diz, A Gomez, S Moran, E Condom, M Esteller, A Villanueva & M Sanchez-Cespedes. (2016) Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming. Oncogene 36:9, pages 1287-1296.
Crossref
Crossref
Ji-Yeon Park & Yong-Sung Juhnn. (2017) cAMP signaling increases histone deacetylase 8 expression via the Epac2–Rap1A–Akt pathway in H1299 lung cancer cells. Experimental & Molecular Medicine 49:2, pages e297-e297.
Crossref
Crossref
Haitham Ashoor, Caroline Louis-Brennetot, Isabelle Janoueix-Lerosey, Vladimir B. Bajic & Valentina Boeva. (2017) HMCan-diff: a method to detect changes in histone modifications in cells with different genetic characteristics. Nucleic Acids Research, pages gkw1319.
Crossref
Crossref
Yiwei Yang, Yitong Huang, Zhantong Wang, Hsin-tzu Wang, Baoyu Duan, Dan Ye, Chenxin Wang, Ruiqi Jing, Ye Leng, Jiajie Xi, Wen Chen, Guiying Wang, Wenwen Jia, Songcheng Zhu & Jiuhong Kang. (2016) HDAC10 promotes lung cancer proliferation via AKT phosphorylation. Oncotarget 7:37, pages 59388-59401.
Crossref
Crossref
Carmen Brenner, Judith Luciani, Martin Bizet, Matladi Ndlovu, Eleonore Josseaux, Sarah Dedeurwaerder, Emilie Calonne, Pascale Putmans, Pierre-Francois Cartron, Matthieu Defrance, François Fuks & Rachel Deplus. (2016) The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent. Oncotarget 7:37, pages 58939-58952.
Crossref
Crossref
Bangqing Liu, Jianfei Song, Jiaqiang Luan, Xiaolin Sun, Jian Bai, Haiyong Wang, Angui Li, Lifei Zhang, Xiaoyan Feng & Zhenzong Du. (2016) Promoter methylation status of tumor suppressor genes and inhibition of expression of DNA methyltransferase 1 in non-small cell lung cancer. Experimental Biology and Medicine 241:14, pages 1531-1539.
Crossref
Crossref
Lu-Hong Li, Pei-Ru Zhang, Pei-Ya Cai & Zhi-Chao Li. (2016) Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway. Biomedicine & Pharmacotherapy 82, pages 161-166.
Crossref
Crossref
Elisabeth D Martinez & Adi F Gazdar. (2016) Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms. Epigenomics 8:3, pages 313-316.
Crossref
Crossref
Li-Li Jiang, Shi-Juan Zhou, Xue-Min Zhang, Hai-Qing Chen & Wei Liu. (2016) Sulforaphane suppresses in vitro and in vivo lung tumorigenesis through downregulation of HDAC activity. Biomedicine & Pharmacotherapy 78, pages 74-80.
Crossref
Crossref
Noël J.-M. Raynal. 2016. Drug Discovery in Cancer Epigenetics. Drug Discovery in Cancer Epigenetics
347
371
.
Shanzhong Yang, Yong-Jig Cho, Lin Jin, Guandou Yuan, Arunima Datta, Phillip Buckhaults & Pran K. Datta. (2015) An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC. Oncotarget 6:32, pages 33237-33252.
Crossref
Crossref
MUNAWWAR ALI KHAN, ARIF HUSSAIN, MADHUMITHA KEDHARI SUNDARAM, USAMA ALALAMI, DIAN GUNASEKERA, LAVEENA RAMESH, AMINA HAMZA & UZMA QURAISHI. (2015) (−)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells. Oncology Reports 33:4, pages 1976-1984.
Crossref
Crossref
Jing Jiang, Jiang-Qi Liu, Jing Li, Meng Li, Hong-Bin Chen, Hao Yan, Li-Hua Mo, Shu-Qi Qiu, Zhi-Gang Liu & Ping-Chang Yang. (2015) Trek1 contributes to maintaining nasal epithelial barrier integrity. Scientific Reports 5:1.
Crossref
Crossref
Wen-Li Zeng, Yao-Wu Chen, Hui Zhou, Jue-Yu Zhou, Min Wei & Rong Shi. (2015) Expression of HERC4 in Lung Cancer and its Correlation with Clinicopathological Parameters. Asian Pacific Journal of Cancer Prevention 16:2, pages 513-517.
Crossref
Crossref
Youwei Zhang, Xiang Wang, Liang Han, Yizhou Zhou & Sanyuan Sun. (2015) Green tea polyphenol EGCG reverse cisplatin resistance of A549/DDP cell line through candidate genes demethylation. Biomedicine & Pharmacotherapy 69, pages 285-290.
Crossref
Crossref
Monica Miozzo, Valentina Vaira & Silvia Maria Sirchia. (2015) Epigenetic alterations in cancer and personalized cancer treatment. Future Oncology 11:2, pages 333-348.
Crossref
Crossref
Frank P. Vendetti, Michael Topper, Peng Huang, Irina Dobromilskaya, Hariharan Easwaran, John Wrangle, Stephen B. Baylin, J. T. Poirier & Charles M. Rudin. (2014) Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer. Oncotarget 6:1, pages 56-70.
Crossref
Crossref
Xian-wei Ye, Hong Yu, Yan-kun Jin, Xiao-ting Jing, Mei Xu, Zi-fen Wan & Xiang-yan Zhang. (2015) miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells. The Clinical Respiratory Journal 9:1, pages 27-33.
Crossref
Crossref
Peng Zhang, Ying Liu, Qianjin Lu & Christopher Chang. 2015. Personalized Epigenetics. Personalized Epigenetics
553
571
.
Kenneth Lundstrom. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
15
39
.
Yu Guo, Amr H. Sawalha & Qianjin Lu. (2014) Epigenetics in the treatment of systemic lupus erythematosus: Potential clinical application. Clinical Immunology 155:1, pages 79-90.
Crossref
Crossref
Alexander Drilon, Hirofumi Sugita, Camelia S. Sima, Marjorie Zauderer, Charles M. Rudin, Mark G. Kris, Valerie W. Rusch & Christopher G. Azzoli. (2014) A Prospective Study of Tumor Suppressor Gene Methylation as a Prognostic Biomarker in Surgically Resected Stage I to IIIA Non–Small-Cell Lung Cancers. Journal of Thoracic Oncology 9:9, pages 1272-1277.
Crossref
Crossref
Mehmet Topcul & Idil Cetin. (2014) Endpoint of Cancer Treatment: Targeted Therapies. Asian Pacific Journal of Cancer Prevention 15:11, pages 4395-4403.
Crossref
Crossref
Yanwei Qing, Haiyan Hu, Yuan Liu, Tao Feng, Wei Meng, Ling Jiang, Yongning Sun & Yang Yao. (2014) Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter. Cell Biology International 38:5, pages 563-570.
Crossref
Crossref
Yang Ke, Weiyong Zhao, Jie Xiong & Rubo Cao. (2013) Downregulation of miR‐16 promotes growth and motility by targeting HDGF in non‐small cell lung cancer cells. FEBS Letters 587:18, pages 3153-3157.
Crossref
Crossref